At three years old, Quinn is feisty, mischievous and fiercely independent. Her dayhome provider is quick to say Quinn is ...

Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

"AISAP is proud to collaborate with forward-thinking practices and community partners like Amavita," said Roni Attali, AISAP ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Amavita has started using AISAP’s AI-powered POCUS diagnostic in community settings for aortic stenosis screening.

CEO John McCutcheon is adamant the US Food & Drug Administration (FDA) will approve the company's Wise, the world’s first ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released topline results from its Phase 2 FIGHT DMD trial. The study evaluated ...

Bhubaneswar: The Kalinga Institute of Medical Sciences (KIMS) here has become the first in Odisha to introduce the ...

The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...